Search results for abx831506

Naxitamab, Abbexa, abx831506

Naxitamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Ganglioside GD2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Naxitamab is a chimeric humanized monoclonal antibody targeting the GD2 antigen. GD2 antigen is expressed on the surface of tumors generated by neuroectoderm, including neuroblastoma, melanoma and osteosarcoma. By binding to the GD2 antigen on the tumor surface, naxitamab can trigger antibody-mediated cytotoxicity and activate the complement system in the immune system to achieve the effect of killing tumors.